Winasorb Flex

Quick links to important sections

Winasorb Flex

Method of action: Miorelaxant

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Winasorb Flex

Quick Facts

Property Description
Active ingredients Acetaminophen (Paracetamol), Chlorzoxazone
Form Oral tablet or capsule
Pharmacological class Non-opioid analgesic and Skeletal muscle relaxant
Common purpose Relief of pain associated with muscle spasm
Origin Synthetic combination product (FDC)

What Type of Medicine is Winasorb Flex?

Winasorb Flex is a pharmaceutical combination drug designed for systemic use, typically administered as an oral tablet or capsule. It is classified pharmacologically as a skeletal muscle relaxant and a non-opioid analgesic. This fixed-dose combination (FDC) is widely clinically recognized for its dual-action profile, which addresses muscle discomfort that benefits from both relaxing muscle tension and reducing pain signals.

This product's formulation is a popular example of a combination therapy for musculoskeletal discomfort. As a synthetic compound product, Winasorb Flex provides a single preparation, making it a convenient option compared to taking two separate medications.

Composition: What Ingredients Make Up Winasorb Flex?

The two active ingredients in Winasorb Flex are Acetaminophen (Paracetamol) and Chlorzoxazone. Acetaminophen provides the well-known analgesic (pain-relieving) and antipyretic (fever-reducing) action. Chlorzoxazone is the component classified as a centrally acting skeletal muscle relaxant and is used as an adjunct to physical therapy and rest to relieve pain and stiffness caused by muscle strains and sprains.

The synergistic effect of these two drugs is supported by pharmacological studies confirming their rapid absorption after oral administration. The muscle relaxant works on the central nervous system to inhibit the reflex arcs that cause involuntary muscle spasms, while the analgesic component simultaneously reduces the accompanying pain sensation.

What is the General Purpose of This Combination?

The general purpose of Winasorb Flex is to provide relief for discomfort where both pain and muscle tension are present, such as in cases of acute back strain or neck stiffness. By combining an analgesic with a muscle relaxant, the product offers a robust therapeutic approach to ease the physical symptoms of muscle spasms and tightness. The medicine helps reduce the intensity of pain while simultaneously working to calm the underlying muscle hyperactivity.

What side effects are possible with Winasorb Flex?

Possible Side Effects and Safety Information

Winasorb Flex, a combination of Acetaminophen and Chlorzoxazone, has a safety profile established through regulatory classification of adverse reactions. These effects are grouped by the body systems they affect, which helps structure the understanding of the medicine's risks.


Adverse Reaction Classifications

Side effects commonly documented in regulatory labeling are primarily associated with the Nervous System and the Gastrointestinal System. Common reactions include drowsiness, dizziness, nausea, and vomiting. Rarer, yet significant, reactions include severe allergic events like anaphylaxis and certain blood dyscrasias.


Serious Safety Considerations

The most serious risk documented in official safety information is Severe Hepatotoxicity (liver damage). Both active components are associated with this risk, with the Acetaminophen component carrying explicit regulatory warnings regarding risk associated with the cumulative daily dose and co-administration with other acetaminophen-containing products. Rare, but critical, risks also include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson syndrome.


Population-Specific Safety Notes

Official labeling requires specific attention for certain populations. The medicine's use is constrained in individuals with severe hepatic impairment due to the enhanced risk of liver damage. Additionally, caution is noted for older adults due to their potential increased susceptibility to CNS-related effects like drowsiness and dizziness.

Overdose and Emergency Response

Overdose and When to Seek Help

Winasorb Flex is a combination product containing Paracetamol (also known as Acetaminophen) and Chlorzoxazone. Taking more than the recommended dose can lead to serious consequences, particularly due to the Paracetamol component, which carries a risk of severe, potentially fatal, liver damage (hepatotoxicity).

Overdose Presentations

Symptoms of a Paracetamol overdose may not appear until 12 to 24 hours or more after ingestion, and initially may be non-specific, resembling flu or cold symptoms. The signs often occur in stages and can include:

  • Early Phase: Nausea, vomiting, loss of appetite, pale skin, sweating, and stomach pain, especially in the upper right side of the abdomen.
  • Late Phase: Symptoms of severe liver damage, such as jaundice (yellowing of the skin and eyes), confusion, bleeding, and coma. Liver failure is a critical risk.

Overdose of Chlorzoxazone can present primarily with central nervous system depression, including drowsiness, dizziness, lightheadedness, and potentially leading to respiratory depression or coma in severe cases.

Required Emergency Action

Urgent medical attention is required immediately for any suspected overdose, even if no symptoms are apparent. Time is a critical factor in treating Paracetamol toxicity. Delaying treatment until symptoms of liver damage appear significantly reduces the chance of a good outcome.

  1. Stop taking the medication.
  2. Call an emergency medical service or Poison Control center right away.
  3. Provide the healthcare professionals with details about the amount taken and the time of ingestion. Specific antidotes, such as N-acetylcysteine (NAC), are used to counteract Paracetamol toxicity, and are most effective when administered within eight hours of the overdose.

Therapeutic Uses of Winasorb Flex

What Winasorb Flex Treats: Main Uses and Benefits

Winasorb Flex is commonly used across conditions presenting with acute or disruptive episodes where symptoms related to physical discomfort are associated with symptoms of increased muscular activity. This combination is considered relevant for providing supportive relief when discomfort and tension occur together. The medication is applied for the relief of discomfort associated with acute, painful musculoskeletal conditions.


This medication is applied in addressing symptom clusters that may become intense or disruptive, specifically in situations where muscle spasms and pain are the primary concern. It is relevant for conditions associated with sudden, painful manifestations, such as acute back strain, muscle sprains, neck discomfort, and certain muscle-contraction headaches. The symptomatic relief may assist with general comfort and contributes to maintaining functional stability during episodes of heightened symptomatic burden.

“It is commonly used when short-term symptomatic assistance is needed for discomfort associated with acute muscle issues.”


Quick Fact: Target Symptom Domain: Pain and Spasm

Property Description
Primary Focus Acute, painful musculoskeletal conditions
Symptom Goal Easing of spasm, stiffness, and associated pain
Use Context Short-term symptomatic support

Winasorb Flex provides supportive relief when symptoms that interfere with daily functioning are present, contributing to a sense of stability when manifestations are more noticeable. It may assist with reducing physical stiffness and tension in conditions associated with acute or disruptive episodes.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Winasorb Flex?

The eligibility for Winasorb Flex, a combination of Acetaminophen and Chlorzoxazone, is strictly governed by regulatory guidelines, focusing on avoiding documented risks associated with both ingredients.


Contraindications: Populations Who Must Not Use

Use is absolutely prohibited (contraindicated) for individuals with a known hypersensitivity or allergy to Acetaminophen, Chlorzoxazone, or any other component in the medicine. It must also not be used by patients diagnosed with severe hepatic impairment or severe active liver disease due to the risk of serious liver toxicity.


Restricted and Conditional Use

The medicine is generally indicated for adults. However, official labeling imposes restrictions on several populations:

  • Pediatric Patients: Safety and effectiveness for the Chlorzoxazone component are not established in the pediatric population; therefore, use is generally not recommended.
  • Older Adults (Geriatric): Use requires special caution due to increased susceptibility to side effects and age-related liver concerns.
  • Liver and Kidney Conditions: Patients with pre-existing, non-severe hepatic impairment or renal impairment should use the medicine with caution.
  • Pregnancy and Lactation: Safe use is not established. Use is restricted to situations where a healthcare professional determines the benefit outweighs the unknown potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the documented interaction profile for the active ingredient, Paracetamol (Acetaminophen), based on official regulatory labeling.


Clinically Significant Interactions

Interacting Substance/Class Interaction Type Constraint/Requirement
Coumarins (e.g., Warfarin) Pharmacodynamic Enhancement Requires monitoring of coagulation status with prolonged, regular Paracetamol use.
Hepatic Enzyme Inducers & Alcohol Increased Toxicity Risk Use caution; risk of hepatotoxicity is increased by chronic alcohol use or concurrent use of inducing agents (e.g., phenytoin, rifampicin).
Cholestyramine Absorption Interference Requires a timing separation; must be administered at least one hour before or after Paracetamol.
Metoclopramide/Domperidone Absorption Rate Alteration Increases the rate of Paracetamol absorption.
Probenecid Elimination Inhibition Requires dose adjustment or monitoring due to inhibition of Paracetamol's renal excretion.
Other Paracetamol Products Additive Effect Do not use simultaneously to avoid exceeding the maximum daily dose.

Interaction-Context Notes

The enhancement of the anticoagulant effect of coumarins is typically associated with regular, prolonged daily administration of Paracetamol, not occasional use. The risk of toxicity is heightened in patients who are malnourished or have existing liver impairment. Concomitant use with flucloxacillin has been associated with a risk of high anion gap metabolic acidosis (HAGMA) in patients with specific underlying risk factors, which warrants careful consideration.

Mechanism of Action

Central Mechanism of Action

Winasorb Flex utilizes a fixed-dose combination strategy resulting in the coordinated modulation of two distinct central pathways: nociceptive transmission and involuntary motor output. Both components exert their primary pharmacological influence within the central nervous system ( CNS).

Acetaminophen drives the modulation of nociceptive transmission through its interaction with central pathways. Its mechanism involves the inhibition of central Cyclooxygenase ( COX) activity and the indirect modulation of the TRPV1 receptor. This initiates signaling changes that modify the effective transmission of central nociceptive information, leading to an elevated threshold for pain pathway activation.

Chlorzoxazone focuses on dampening motor reflex hyperactivity. Its mechanism involves the activation of specific potassium channels on motor neurons, which promotes neuronal hyperpolarization. This functionally suppresses the excessive nerve firing within the spinal cord's multisynaptic reflex arcs associated with involuntary motor hyperactivity.

This integrated central pathway regulation facilitates the simultaneous reduction of abnormal motor output and the modification of nociceptive signaling.

Dosage and Administration Information

How Winasorb Flex is Used: Official Dosing and Administration

Winasorb Flex is an oral medication administered as a tablet or capsule, following specific guidelines for the combination of Acetaminophen (Paracetamol) and Chlorzoxazone. This information strictly outlines how the medicine is used and does not address its effects or safety profile.


Standard Administration Schedule

Property Administration Detail
Route of Administration Oral (by mouth)
Dosing Frequency Typically 3 to 4 times a day (every 6 to 8 hours)
Duration of Use Intended for short-term symptomatic relief

Key Dosing Rules

  • Adult Dosing: The standard dose for the Chlorzoxazone component ranges from 250 mg to 500 mg per administration. The dose may be increased up to a maximum of 750 mg if the lower dose provides inadequate relief.
  • Maximum Limit: The total daily intake of Acetaminophen (from all sources) must not exceed 4,000 mg (4 g) in a 24-hour period to prevent liver toxicity.
  • Dose Reduction: Official instructions specify that the dose should be reduced as the patient’s condition and symptoms begin to improve.

Population-Specific Use

Adjustments in the administration protocol are outlined for certain patient groups:

  • Older Adults (Geriatric): These patients may be started on a lower initial dose, such as 250 mg of the Chlorzoxazone component, taken every 6 to 12 hours.
  • Hepatic Impairment: Use of the product requires extreme caution and often mandates a strict lower limit on the total daily intake of Acetaminophen (e.g., typically no more than 2 g/day) due to the metabolism of both components.

Recent Clinical Evidence

Winasorb Flex: Recent Clinical Evidence

Evidence for Use in Acute, Painful Musculoskeletal Conditions

Research has explored the use of this medicine, which pairs a muscle relaxant with an analgesic, in conditions characterized by fluctuating or episodic manifestations, such as acute low back pain and painful muscle spasm. Studies primarily involve Randomized Controlled Trials (RCTs) where the medicine or related combinations was observed in adult patients with short-term, acute symptoms. Research highlights changes measured during the study period, focusing on temporary physiological imbalance associated with acute episodes.

What Outcomes Were Examined in Trials?

Researchers examined several types of outcomes related to systemic or functional imbalance. Studies explored how symptoms evolved by measuring both subjective and objective changes. These included patient-reported outcomes describing perceived discomfort (like VAS scores) and objective measures to assess muscle stiffness and spasm. These outcomes capturing phases of heightened symptom activity were studied for a short time frame, as the research was focused on short-term or episodic symptom patterns.

Comparison of Combination Therapy to Analgesic Alone

Clinical research compared the muscle relaxant-analgesic approach against an analgesic alone (Acetaminophen) or a placebo. Data show patterns related to outcomes describing episodic or acute changes, but comparative evidence is lacking for many direct assessments. Systematic reviews evaluating the drug class suggest that while it appears to perform differently than placebo in some contexts, the findings were mixed or inconsistent when directly comparing the combination approach to monotherapy. Research provides insight into short-term changes, but the specific patterns of response of the dual-component approach is not fully established across all studies.

Long-Term Studies and Evidence Gaps

The clinical trials were evaluated in research exploring short-term symptom changes, meaning follow-up durations were limited, typically lasting 7 days or less. Consequently, long-term effects are not fully established. Also, data for certain groups remain insufficient, as the main research was studied for the general adult population. Evidence quality varies across studies, and the overall certainty remains low due to these research limitation frames. The specific research for this fixed-dose combination (FDC) is often extrapolated from the broader class of muscle relaxants, meaning data are still emerging for this precise pairing.

Key Studies & References

  1. Chlorzoxazone Tablet DailyMed Monograph (NIH/NLM)
  2. Chlorzoxazone: MedlinePlus Drug Information Monograph

Frequently Asked Questions (FAQ)

Common questions about Winasorb Flex (FAQ)

Q: Is Winasorb Flex a type of NSAID?

A: No. Winasorb Flex is classified as a skeletal muscle relaxant combined with a non-opioid analgesic (pain reliever).

Official regulatory information indicates that the Acetaminophen component does not carry the same risk of classic gastrointestinal irritation that is typically associated with Nonsteroidal Anti-inflammatory Drugs (NSAIDs).


Q: How long does it typically take to feel the effects of Winasorb Flex?

A: Studies indicate that the onset of action for the muscle relaxant component is usually observed within one hour of taking the medication.

The concentrations of both active ingredients in the bloodstream typically reach their peak within 45 to 90 minutes after oral administration.


Q: Is Winasorb Flex available without a prescription?

A: According to regulatory classifications in many regions, the muscle relaxant component of this medicine, Chlorzoxazone, is categorized as a prescription-only drug.

Therefore, Winasorb Flex generally requires a prescription from a licensed healthcare professional.


Q: Does Winasorb Flex interact with blood pressure medicines?

A: Official regulatory labels advise informing a healthcare professional about all medications being taken, including any for blood pressure.

This allows them to assess for potential interactions and determine if any monitoring is required for safe use.


Q: Can Winasorb Flex be taken if I am already taking vitamins or supplements?

A: Yes, official sources strongly advise informing a healthcare professional about all over-the-counter products, including vitamins, minerals, and dietary supplements.

This disclosure allows a healthcare professional to check for potential interactions.


Q: Are there any dietary restrictions while using Winasorb Flex?

A: Official guidance recommends avoiding or limiting alcohol consumption during the use of this medicine.

This is because alcohol can increase the risk of liver damage associated with the Acetaminophen component and can increase central nervous system side effects like drowsiness from the Chlorzoxazone component.


Q: What is the intended duration of action for a single dose?

A: The pharmacological effect of the muscle relaxant component, Chlorzoxazone, is described as typically lasting for approximately three to four hours after an oral dose.

This duration guides the recommended dosing frequency.


Q: Is it possible for Winasorb Flex to affect my sleep?

A: Yes, it is possible for this medicine to affect sleep.

Drowsiness is listed in official documents as a common side effect of the muscle relaxant component. Additionally, in some reports, insomnia (difficulty sleeping) has been noted with a low frequency.


Q: Are there any common interactions with herbal remedies?

A: Official documents advise informing a healthcare provider about all herbal remedies being taken.

Certain herbs, such as St. John’s Wort, have been known to interact with the active ingredients of medications like this, potentially changing how the drug works in the body.


Q: What should I do if I miss a dose of Winasorb Flex?

A: Official guidance on a missed dose is to take it as soon as it is remembered, unless it is almost time for the next scheduled dose.

In that situation, the general instruction is to skip the missed dose and resume the regular schedule. Taking two doses at the same time to compensate for a missed one is typically advised against.


Q: Is Winasorb Flex described as having an anti-inflammatory property?

A: No. Winasorb Flex is categorized as a skeletal muscle relaxant and a non-opioid analgesic (pain reliever).

The Acetaminophen component provides pain relief and reduces fever (antipyretic action), but it is not classified as an anti-inflammatory drug in the way that NSAIDs are.


Q: Can Winasorb Flex be taken with food?

A: Yes, official patient information indicates that this medication can be taken with or without food.

Taking the medicine with a glass of water is generally recommended. If minor stomach upset occurs, taking the medicine with food is generally mentioned as an option in patient information.


Q: Has Winasorb Flex been studied in children or teenagers?

A: Official documents state that the safety and effectiveness of the muscle relaxant component have not been established in the pediatric population (children and teenagers).

As a result, its use is generally restricted, and the decision regarding use must be made by a healthcare professional.


Q: Does Winasorb Flex interact with birth control pills?

A: Specific major interactions with hormonal contraceptives are not commonly listed in regulatory documents.

However, general guidance advises that healthcare professionals must be informed about all medicines being taken, including birth control pills, for an accurate risk assessment and necessary monitoring.


Q: How quickly does Winasorb Flex leave the body?

A: Official pharmacological data indicates that the active ingredients are quickly processed by the body.

The muscle relaxant component has an elimination half-life of about one hour, while the analgesic component ranges from 1.5 to 3.5 hours. The medicine is metabolized rapidly and primarily excreted through the urine.


Q: Are there long-term side effects associated with Winasorb Flex?

A: Due to the inclusion of Acetaminophen, there is a potential risk of serious liver toxicity associated with cumulative daily doses.

For this reason, official guidance emphasizes that the medicine should only be used for the short duration recommended by a healthcare provider, as long-term effects are not fully established in clinical trials.


Q: Can Winasorb Flex be crushed or chewed?

A: The product is officially specified as a tablet intended for oral administration (swallowed whole).

Unless explicit instructions are provided by the manufacturer or a healthcare provider, tablets are typically advised not to be crushed or chewed to preserve the drug's intended action and release profile.


Q: Why is Winasorb Flex sometimes listed with other prescription medications?

A: This medicine is listed with other prescription medications because the muscle relaxant component, Chlorzoxazone, is categorized by regulatory bodies as a prescription-only drug (Rx).

This means it is only intended for use under the direction and supervision of a licensed healthcare professional.


Q: Does Winasorb Flex affect the heart in any way?

A: Official product information for similar combinations has noted rare, temporary changes in the cardiovascular system.

These include reports of tachycardia (an increased heart rate) and vasodilation (widening of blood vessels). These events are rare, and regulatory documents have not established a definite causal link to the medication.


Q: Is there a different formulation of Winasorb Flex (e.g., liquid, capsule)?

A: The fixed-dose combination product of the active ingredients is generally available in the form of an oral tablet for use.

While individual components may exist in other formulations, the combination product is typically distributed as a tablet.


Q: Is Winasorb Flex classified as a scheduled drug?

A: No, official regulatory bodies do not classify this medicine as a controlled or scheduled drug.

It is categorized pharmacologically as a non-opioid analgesic and a skeletal muscle relaxant.


Q: What is the meaning of the strength indicated on the box?

A: The number listed as the strength on the box (e.g., 250 mg or 500 mg) refers to the precise amount of the active muscle relaxant component (Chlorzoxazone) contained within each individual tablet.

This strength is used by healthcare professionals to determine the correct administration schedule.


Q: I read that Winasorb Flex is used for osteoarthritis; is that correct?

A: The official indication for this medicine is to provide relief for discomfort associated with acute musculoskeletal conditions, such as short-term muscle spasm and associated pain.

While it may provide relief for symptoms related to conditions like arthritis, it is not primarily indicated for long-term or chronic use in conditions like osteoarthritis.


Q: How does the medicine know where the pain is located?

A: This medication is a centrally-acting agent, meaning it works throughout your body by influencing the Central Nervous System (CNS), specifically in the spinal cord and certain brain areas.

It does not travel directly to the site of pain but reduces pain signals and muscle reflex activity across the entire body.


Q: Does Winasorb Flex interact with acid reflux medications?

A: Regulatory guidance notes interactions with specific gastrointestinal motility drugs that can alter the rate at which the Acetaminophen component is absorbed into the bloodstream.

It is advised that patients discuss any potential interaction with their healthcare professional.

How should Winasorb Flex be stored and disposed of?

Storage and Protection Requirements

Official regulatory documents require that Winasorb Flex be stored under specific conditions to maintain its quality and potency. This medicine must be kept at a controlled room temperature (typically between 59 F and 77 F or 15 C and 25 C), unless otherwise instructed on the label. To prevent degradation, the product must be protected from light and moisture and should not be frozen or stored in environments with high humidity, such as a bathroom.

Always keep Winasorb Flex in its original container and ensure it is stored out of the sight and reach of children to prevent accidental ingestion.

Official Disposal Instructions

When disposing of unused, unwanted, or expired Winasorb Flex, the official preference is to use a drug take-back program or an authorized collection site, such as those available at certain pharmacies or law enforcement locations. This method ensures the medicine is destroyed according to pharmaceutical waste protocols.

Do not dispose of the medicine by flushing it down a toilet or pouring it down a sink, as this can lead to environmental contamination, unless the drug is specifically listed on the U.S. FDA's flush list. If take-back options are unavailable and the drug is not on the flush list, you may dispose of it in the household trash after mixing it with an undesirable substance (like coffee grounds or kitty litter) and sealing it in a plastic bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Winasorb Flex found in:

A-Z Index: